25
total announcements
RUBICON.NS · 15 min delayed
Rubicon Research Limited
Rubicon Research Limited has informed the Exchange regarding the allotment of 1,49,158 fully paid-up equity shares of INR 1 each, pursuant to exercise of employee stock options under the Rubicon Research Limited - Employee Stock Option Scheme 2022.
Rubicon Research Limited
Rubicon Research Limited has submitted a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming compliance for the quarter ended June 30, 2026.
Rubicon Research Limited
Rubicon Research Limited has informed the Exchange about a US FDA inspection of its manufacturing facility in Pithampur, Madhya Pradesh. The inspection was unannounced and resulted in a Form 483 with 2 procedural observations. The company is confident of working with the regulator to resolve the issues.
Rubicon Research Limited
Rubicon Research Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, due to the declaration of Unaudited Financial Results for the quarter and year ending June 30, 2026.
Rubicon Research Limited
Rubicon Research Limited has filed a disclosure with the NSE under Regulations 31(4) and 31(5) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This filing relates to the mandatory annual disclosure by promoters concerning any encumbrances, such as pledged shares, on their holdings. While the announcement does not detail specific financial figures, it signifies the company's compliance with crucial transparency requirements. For investors, such disclosures are important for assessing promoter financial health and potential risks associated with pledged shares, which can influence market perception and stock stability.